1. Introduction
Cystic echinococcosis (CE) is one of the world’s major zoonotic diseases, which is characterized by the development of large cysts in liver, lungs and other organs of both humans and livestock. The infection is caused by the dog tapeworm, E. granulosus, in humans and animals alike [1]. Echinococcosis is one of the most important zoonotic parasitic diseases worldwide and in the Mediterranean region, largely due to extensive home slaughtering practices and the presence of numerous stray dogs with access to offal [2]-[4]. The disease is highly endemic in the whole of the Mediterranean Basin and adjacent countries, including Greece, Türkiye, Syria, Palestine, Lebanon, Jordan, Egypt, Libya, Morocco, Tunisia and Algeria [5] [6]. Reports indicate up to 40% of sheep and 30% of dogs in Lebanon, and 60% of aged sheep and 20% of dogs in Jordan [7] have been infected. In Palestine, studies on E. granulosus are lacking. However, surgical records from West Bank hospitals between 1990 and 1997, a total of 390 revealed 390 surgically confirmed CE cases, with an overall mean annual surgical incidence of 3.1 per 100,000. The highest annual surgical incidence (16.8 per 100,000) was observed in Yata town near Hebron [8]. A study in 2002 found a seroprevalence of CE among school children in Palestine to be 2.4% [9]. Between 2010 and 2015, a total of 353 CE patients were identified from records of 30 hospitals in the West Bank and Gaza [10].
To enable specific identification of Echinococcus species, various molecular characterization techniques have been adopted, including PCR-RFLP [11] and loop-mediated isothermal amplification (LAMP) [12] [13]. However, determining the infection rate in dogs is crucial for epidemiologic studies, surveillance, and control programs, as well as assessing transmission dynamics and infection risks. Traditionally, dog infection has been determined post-mortem by identifying worms in intestinal washes or following Arecoline purgation. More recently, an enzyme immunoassay-based coproantigen test has been developed for this purpose, offering genus-specific detection with approximately 97% specificity (when worm burdens are more than 50 - 100 worms) [14] [15]. However, this method’s sensitivity for natural Echinococcus granulosus infection averages only about 60% [16] [17]. To address these limitations and improve detection sensitivity and species-specificity, molecular tools have been developed. These tools have facilitated the differentiation of Taeniidae worms based on morphological and molecular characteristics [18] for identifying Echinococcus granulosus and E. multilocularis in infected dogs [13] [19] [20]. Data accumulation of tapeworm DNA sequences, including mitochondrial DNA, has enabled to development of molecular diagnostic tools for distinguishing between several human Taenia species [21]-[24].
Over recent decades, molecular studies, primarily based on mitochondrial genes, have described several genotypes or species within E. granulosus. These include E. granulosus (Genotypes G1-G3), E. equinus (G4), E. ortleppi (G5), E. canadensis (G6-G10) and E. felidis (‘lion strain’). The existence of the human-specific genotype G9 is controversial [25]. Echinococcus felidis had been described in 1937 from African lions, but was later included in Echinococcus granulosus as a subspecies or a strain [26] and [11]. Further research has clarified the distinction between mitochondrial genotypes, with G1 and G3 now considered as a single species of E. granulosus, while G2 is more closely related to G3 [27]. Additionally, based on six nuclear loci, G6/G7 and G8/G10 genotypes are considered distinct species [28]. Furthermore, it has been proposed that camel and pig strains of E. granulosus constitute a single species (E. intermedius) [29]. Two new species, E. shiquicus in small mammals from the Tibetan plateau and E. felidis in African lions, have recently been identified, although their zoonotic transmission potential remains unknown [30].
In our current study, we introduced a set of primers based on conserved region-found Taeniid tapeworms’ 18s rRNA genes, intended for DNA amplification followed by next-generation (NGS) DNA sequencing. The NGS technology allows mass sequencing of genetic material, facilitating the simultaneous production of a vast array of genomic information from multiple organisms amplified by the same PCR reactions in parallel. Moreover, NGS provides a quantitative counting measurement for each amplified amplicon, reflecting the intensity of infection.
2. Material and Methods
2.1. Tapeworms Genomic DNA
Previously amplified genomic DNA or newly extracted DNA from various tapeworms from the Al-Quds University collection were utilized in this study, encompassing different Echinococcus species and Taenia species. DNA from different worms was extracted using Dneasy Blood & Tissue Kits (Qiagene, Germany).
2.2. Dog Fecal Samples
A total of 50 samples were collected from household dogs and sheep owners by farmers in Yatta town, situated in the southern part of Hebron district in Palestine. For each collected sample, 5 grams of fecal materials were placed in 50 ml sterile screw-cap tube. Samples were stored at −20˚C until DNA extraction.
2.3. DNA Extraction
DNA was extracted from dogs’ feces using QIAamp PowerFecal Pro DNA Kit (Qiagen), following manufacturers’ instructions. DNA extraction was performed in duplicate to maximize the concentration of prepared DNA. Approximately 0.2 grams of fecal sample suspended in 100 μl phosphate buffer saline were used each time. DNA was eluted in 50 μl double distilled water and stored at −20˚C.
2.4. PCR Primers
A new set of PCR primers was designed based on DNA alignment of tapeworm (Echinococcus and Taenia species) 18s rDNA genes available in the GenBank. The newly defined primers (Taen18S1D: GGTTTATTGGATCGTACCC and Taen18S1R: CTGTAACAATTATCCAGAGTC) were based on optimally recognized consensus sequences in the aligned regions, spanning a unique sequence for aligned tapeworms 18s rRNA genes, identifiable later by next generation sequencing. The PCR reactions were carried out in 25 μl containing (2x ready mix Taq DNA polymerase mixture (Takara, Japan).
2.5. DNA Amplification by Polymerase Chain Reaction
DNA amplification of Taeniid tapeworms’ DNA was conducted using ready-to-use dry Taq DNA polymerase (Syntezza, Jerusalem). The primers were used in a concentration of 20 picomoles, with approximately 5ng of tapeworm genomic DNA. For PCR amplification using extracted DNA from dogs fecal samples, 5 μl from the extracted DNA was used. The PCR amplification program consisted of an initial denaturation at 95˚C for 5 min, followed by 35 cycles (30 seconds at 95˚C, annealing at 55˚C for 30 seconds, and extension at 72˚C for 1 minute). The amplified PCR products were analyzed on 1% agarose gel electrophoresis in TAE buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA).
2.6. PCR Amplification for Next-Generation DNA Sequencing
Illumina Miseq (Illumina, USA) NGS strategy, as used for microbiome MiSeq DNA analysis, was adopted for DNA sequence analysis [31]. This involves two PCR steps: amplification and PCR product index labeling adapted from the bacterial 16s rRNA Metagenomic sequencing library preparation (Illumina, USA). The previously designed primers were modified for NGS analysis, adding the following overhang adaptors to the 5'-prime end of each forward and reverse primers: (forward adaptor: TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG, reverse adaptor: GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA G). The PCR products from the first PCR were individually purified using 0.6X volumes of AMPure XP magnetic beads (AMPure XP beads kit/Beckman Coulter, USA), followed by a second PCR reaction to attach the dual indices (S5 and N7) linked to Illumina sequencing adaptors. After index labeling of each PCR product, another DNA amplicon purification was performed using AMPure XP magnetic beads, followed by combining all PCR products into one tube, referred to as the NGS library. NGS DNA sequencing was conducted by an outsourcing service company (sequencing was performed on Miseq machine using 500 cycle kit from Illumina, USA).
2.7. Bioinformatics Analysis
Raw Illumina sequencing data were generated from all analyzed PCR amplicons as FASTQ files of read1 (forward) and read2 (reverse) for each individual sample. These sequence reads were uploaded to Galaxy platform at (usegalaxy.org) for further sequence processing and analysis [32]. Initially, raw sequences were filtered for quality control at a Phred score of 20, equivalent to 99% confidence of each nucleotide. Following this, forward and reverse reads were merged, and the amplified specific genes were selected based on their specific sequence length and sequence identity. The selected sequence reads from each PCR product was analyzed for sequence homology above 97% using BLAST analysis tools.
3. Results
3.1. A note on Detecting Echinococcus Parasite’s DNA from
Dogs’ Fecal Samples Extracted
The main objective of this study was to assess the prevalence of echinococcus parasites in dogs using established molecular methods [19] [33]. Surprisingly, both PCR systems revealed a large number of infected dogs upon examination of DNA extracted from collected dog fecal samples. Figure 1 displays the agarose gel electrophoresis analysis of the amplified E. granulosus mitochondrial cox1 gene, clearly indicating 38 positive samples out of the total analyzed 40 samples. The same results were obtained upon retesting the same samples, with an amplification band of 446 bp size, using a PCR system targeting a repetitive gene (EgG1 Hae III repeat) in the E. granulosus genome. As depicted in Figure 1, the results of this PCR showed 38 positive samples out of 40 tested. Efforts were made to confirm the positivity of these results through DNA sequence analysis. However, obtaining sequencing information from these bands was challenging, particularly for the second PCR targeting the E. granulosus repetitive gene, due to the amplification of multiple bands, rendering conventional Sanger DNA sequencing ineffective. Conversely, the cox1 amplified bands are discrete, but the sequence information contained many unknown bases (N), indicating several amplicon types with the same band size. Consequently, the search for more specific primers capable of yielding accurate and reliable results without requiring further DNA sequence analysis ensued.
3.2. PCR Primers Used to Amplified Teaniid Tapeworms
Efforts were made to design potential primers for amplifying teaniid tapeworm DNA and conducting sequence analysis by NGS. Different primers were selected based on tapeworm sequences of the mitochondrial and 18s rDNA genes. One set of PCR primers, designed based on 18s rDNA genes, demonstrated promise for this purpose. Initially successful in amplifying 5ng of genomic DNA from E. granulosus, E. multilocularis, and Dipylidium caninum (Figure 2), these primers showed slight differences in the amplified band size, especially when comparing Echinococcus species with D. caninum. The sensitivity limit of these PCR primers was tested by amplifying pure E. granulosus genomic DNA. Demonstrating successful amplification across several twofold dilutions starting from 1 ng/μl, (1, 0.5, 0.25, 0.1, 0.05, and 0.02 ng/μl) with the lowest dilution endpoint not reached (Figure 3).
![]()
Figure 1. PCR amplification targeting DNA extracted from dogs fecal samples using E. granulosus cox1 PCR system (above) and E. granulosus (EgG1 Hae III repeat) PCR system (lower gel).
Figure 2. Agarose gel electrophoresis of amplified PCR products from 5 ng of genomic DNA. 1: E. granulosus, 2: Dipylidium caninum, 3: E. multilocularis, 4: Negative control. M: DNA size marker.
Figure 3. PCR sensitivity test of the three candidate PCR systems. Several dilutions of E. granulosus genomic DNA control was used (1, 0.5, 0.25, 0.1, 0.05, and 0.02 ng/ml). M = DNA size marker.
3.3. Adapting the Selected Primers for Tapeworm DNA Amplification Suitable for NGS Analysis
Forward and reverse adapters were added to the designed primers to enable sequencing using NGS methodology. The primers were first used to amplify genomic DNA extracted from various available Taeniid tapeworms (E. granulosus, E. multilocularis, Taenia serialis, T. pisiformis, T. ovis, T. hydatigenia, Multiceps multiceps, D. caninum). This PCR system that targeted 18s rDNA fragment successfully amplified all the tested species with relatively similar strength. PCR amplification targeting the tested tapeworms and using the designed primers showed slight differences in the amplified bands (Figure 4). Subsequent NGS DNA sequence analysis of the PCR amplified bands precisely identified the exact band size for each of the tested tapeworm species (Table 1). Despite some species exhibiting similar band sizes, NGS sequencing would discriminate between them. Furthermore, the presence of sufficient sequence differences between all tested tapeworm species, with the primers conserved sequences, ensures accurate identification.
![]()
Figure 4. Agarose gel electrophoresis of PCR DNA amplification using the designed primers targeting 1ng genomic DNA extracted from the following tapeworms (1-2: E. granulosus. 3-4: E. multilocularis, 5: T. pisiformis, 6-7: Multiceps multiceps, 8: T. hydatigenia, 9: T. ovis, 10-11: D. caninum). M: DNA size marker.
Table 1. Total number of reads obtained after NGS-DNA sequencing of PCR amplification targeting various tapeworm genomic DNA.
|
|
Number of reads in tested reference samples |
Species |
PCR amplified band (bp) |
S1 |
S2 |
S3 |
S4 |
S5 |
S6 |
S7 |
S8 |
S9 |
S10 |
S11 |
S12 |
S13 |
Echinococcus granulosus |
225/224 |
3266 |
4828 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1244 |
33 |
Echinococcus multilocularis |
216 - 218 |
0 |
0 |
5557 |
1679 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
14 |
11 |
Taenia pisiformis |
263 |
0 |
0 |
0 |
0 |
1684 |
0 |
0 |
0 |
0 |
0 |
0 |
6 |
7 |
Taenia multiceps |
255 - 259 |
0 |
0 |
0 |
0 |
0 |
2175 |
1277 |
0 |
0 |
0 |
0 |
6 |
31 |
Taenia hydatigena |
267 - 270 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1226 |
0 |
0 |
0 |
67 |
5 |
Taenia ovis |
264 - 465 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2180 |
0 |
0 |
12 |
19 |
Dipylidium caninum |
230 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
3136 |
2394 |
21 |
2432 |
Mix of all species (total reads) |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
|
1370 |
2538 |
Adapting PCR amplification reaction to next-generation sequence analysis enables quantitative estimation of the amplified PCR amplicons from various tapeworm species. As demonstrated in Table 1, it was feasible to accurately count the number of amplicons for each of the tested species through NGS sequencing and subsequent bioinformatics counting analysis. The effectiveness of adapting the classically designed primers for NGS sequencing is underscored by the results of PCR amplification of the mixed tapeworm genomic DNA (samples 12 and 13 in Table 1).
3.4. Applying PCR Systems to DNA Extracted from Dog-Fecal Samples
The developed PCR system was applied to amplify DNA extracted from dogs’ fecal samples. A total of 50 samples collected from Yatta town were used in this part of the study. Although PCR results and agrose gel electrophoresis of the amplified products did not allow for accurate calculation of the number of positive samples, NGS DNA sequence analysis was imperative for confirmation positivity. After analysis of their specific NGS FASTQ data based on sequence length and DNA sequence, 5 samples were found to contain E. granulosus DNA amplicons, showing 98-99% similarity with 18s rDNA gene of E. granulosus. Although we were interested in identifying echinococcus infections in dogs, but we were able to identify D. caninum in 9 dog samples which is another important common Taeniid species in dogs. A finding that shows the importance NGS analysis method in identifying co-infections (Table 2).
Table 2. Analysis of dogs’ fecal samples: NGS-DNA sequence analysis of amplified products using the developed Taeniid PCR system (Total number of samples was 50 dogs).
Identified Taeniid species |
Total number of infected dogs/percentage |
Average number of NGS reads |
Similarity with 18s rDNA genes from GenBank |
E. granulosus |
5 (10%) |
500 - 1300 |
98% - 99% |
D. caninum |
9 (18%) |
400 - 2400 |
98% - 99% |
4. Discussion
Echinococcus parasites are tapeworms of significant zoonotic concern, with dogs serving as their definitive hosts, and transmission to humans occurs through the ingestion of contaminated food or water. Echinococcus tapeworms pose health risks to both dogs and humans, making their accurate identification and effective control imperative for veterinary and public health purposes. Identification of various tapeworm species in dogs’ fecal samples is crucial for effective parasite control and public health management. The most common Taeniid tapeworms found in dogs’ fecal samples include Taenia pisiformis, Taenia hydatigena, and Taenia multiceps, Dipylidium caninum, with Echinococcus species being of particular concern for human health. Dogs become infected after ingesting infected intermediate hosts such as rodents, rabbits, or, as in the case of Echinococcus, the ingestion of infected herbivores’ offal. The infective eggs of these tapeworms are shed into the feces of infected dogs. While differentiation between these Taeniid species often relies on morphological characteristics, molecular techniques such as PCR assays targeting specific DNA sequences have become increasingly valuable for accurate species identification.
Determination of E. granulosus infection in dogs is crucial for assessing the risk of infection, identifying active infection foci, and evaluating control program efficacy. Traditionally, identification of E. granulosus in dogs has relied on methods such as intestinal washes using arecoline purgation. While copro-antigen tests have facilitated large-scale screening of definitive hosts, the development of molecular tools has been prompted by the need for improved detection sensitivity and species-specific detection. Molecular techniques like PCR not only confirm the presence of the parasite but also provide data on infection intensity and transmission dynamics, enabling effective control measures to mitigate the spread of these zoonotic parasites, predicting disease transmission patterns and mitigating potential public health risks [34] [35].
Molecular diagnosis of Taeniid tapeworms in dogs’ fecal samples has been facilitated by PCR assays targeting specific genetic markers offering high sensitivity and specificity even for low parasite burdens. PCR assays targeting regions of the mitochondrial DNA, such as the cytochrome c oxidase subunit 1 (cox1) gene, have been developed for the detection of some Taenia spp. [18] [36]. Similarly, Dipylidium caninum infections have been detected through PCR assays targeting the 18S ribosomal RNA gene [37]. Echinococcus granulosus, identification has been achieved using PCR assays targeting the mitochondrial NADH dehydrogenase subunit 1 (nad1) gene [38]. Furthermore, the development of quantitative PCR (qPCR) assays enables the quantification of parasite DNA in fecal samples, offering a potential tool for monitoring treatment efficacy and assessing environmental contamination levels [39].
The 18s rRNA gene, commonly used for phylogenetic analysis, exhibits a remarkable degree of conservation across diverse taxa, including both Taeniid tapeworms and fungal species. Despite their evolutionary divergence and biological differences, certain regions of the 18s rRNA gene in Taeniid tapeworms and fungal species share notable sequence similarities, reflecting functional constraints on the gene and its role in essential cellular processes conserved across eukaryotes. However, while the overall sequence similarity may exist, specific regions of the 18s rRNA gene can vary significantly, allowing for the discrimination between different taxa. Therefore, while the 18s rRNA gene can be a valuable molecular marker for studying evolutionary relationships and biodiversity, additional genetic markers and complementary analytical techniques are often necessary for accurate taxonomic classification and species identification within these diverse groups.
PCR followed by next-generation sequencing (NGS) offers superior sensitivity and specificity compared to PCR alone for the detection and identification of mixed pathogens in tested samples. PCR amplification enhances the detection of low-abundance sequences, particularly in samples with high background noise or low pathogen concentrations. Subsequently, DNA NGS analysis provides comprehensive sequence information regardless of the mixed amplification of the target DNA, enabling accurate pathogen identification with high sensitivity and specificity [40]. This finding is consistent with many studies in the region that estimated dog infectivity by E. granulosus using traditional methods for worm detection, including Arecoline purging tests [41].
In conclusion, incorporating molecular techniques such as PCR followed by amplicon NGS DNA sequencing and bioinformatics analysis into routine diagnostic protocols enhances the accuracy and efficiency of Taeniid tapeworm detection in dogs. These methods not only allow for the differentiation of Taeniid species but also facilitate the detection of co-infections, thereby contributing to improved parasite control and public health management.